zoledronic acid has been researched along with erythrosine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, JR; Jee, WS; Li, QN; Ma, YF; Müller, K; Pataki, A | 1 |
| Fernandez, SA; Huja, SS; Li, Y; Phillips, C | 1 |
| Al-Nawas, B; Klein, M; Pabst, A; Walter, C; Ziebart, T | 1 |
| Allen, MR; Burr, DB; Kubek, DJ | 1 |
| D'Atri, AM; Fenell, CE; Fernandez, SA; Hueni, S; Huja, SS; Mason, A; Mo, X | 1 |
| Al-Nawas, B; Koch, FP; Pabst, AM; Taylor, KY; Walter, C; Ziebart, T | 1 |
| Draenert, GF; Huetzen, DO; Kämmerer, PW; Nacu, V; Palarie, V; Wagner, W | 1 |
| Hironaka, Y; Marutani, A; Matsuda, R; Motoyama, Y; Nakagawa, I; Nakamura, M; Nakase, H; Nakazawa, T; Nishimura, F; Ouji, N; Ouji, Y; Park, YS; Sugimoto, T; Takeshima, Y; Tamura, K; Tsujimura, T; Yamada, S; Yoshikawa, M | 1 |
8 other study(ies) available for zoledronic acid and erythrosine
| Article | Year |
|---|---|
Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Bone Development; Calcium; Demeclocycline; Diphosphonates; Dose-Response Relationship, Drug; Femur; Fluoresceins; Growth Plate; Hydroxyproline; Imidazoles; Indicators and Reagents; Injections, Subcutaneous; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Tibia; Zoledronic Acid | 1997 |
Zoledronic acid decreases bone formation without causing osteocyte death in mice.
Topics: Alveolar Process; Animals; Bone Density Conservation Agents; Cell Death; Cell Survival; Diphosphonates; Femur; Fluoresceins; Fluorescent Dyes; Imidazoles; L-Lactate Dehydrogenase; Male; Mandible; Maxilla; Mice; Mice, Inbred C57BL; Osteocytes; Osteogenesis; Osteonecrosis; Zoledronic Acid | 2009 |
Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Topics: Apoptosis; Bone Density Conservation Agents; Cell Culture Techniques; Cell Movement; Cell Survival; Cells, Cultured; Clodronic Acid; Diphosphonates; Endothelial Cells; Endothelium, Vascular; Fibroblasts; Fluoresceins; Fluorescent Dyes; Humans; Ibandronic Acid; Imidazoles; In Situ Nick-End Labeling; Nitrogen; Osteoblasts; Pamidronate; Umbilical Veins; Zoledronic Acid | 2011 |
Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.
Topics: Alveolar Process; Animals; Bone Density Conservation Agents; Bone Matrix; Bone Remodeling; Calcification, Physiologic; Coloring Agents; Dentin; Diphosphonates; Female; Femur; Fluoresceins; Fluorescent Dyes; Haversian System; Imidazoles; Mandible; Mice; Mice, Inbred C3H; Necrosis; Osteogenesis; Ovariectomy; Periodontal Ligament; Pharmaceutical Vehicles; Rosaniline Dyes; Tooth Calcification; Zoledronic Acid | 2010 |
Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
Topics: Age Factors; Alveolar Process; Animals; Bicuspid; Bone Density Conservation Agents; Bone Remodeling; Dental Implantation, Endosseous; Diphosphonates; Dogs; Femur; Fluoresceins; Fluorescent Dyes; Imidazoles; L-Lactate Dehydrogenase; Male; Mandible; Mandibular Diseases; Maxilla; Maxillary Diseases; Models, Animal; Orthodontic Anchorage Procedures; Osteogenesis; Osteonecrosis; Random Allocation; Ribs; Tooth Extraction; Wound Healing; Zoledronic Acid | 2011 |
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Topics: Apoptosis; Bone Density Conservation Agents; Cell Culture Techniques; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Clodronic Acid; Coloring Agents; Diphosphonates; Fluoresceins; Fluorescent Dyes; Humans; Ibandronic Acid; Imidazoles; In Situ Nick-End Labeling; Keratinocytes; Mouth Mucosa; Pamidronate; Tetrazolium Salts; Thiazoles; Zoledronic Acid | 2012 |
Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorption; Cell Culture Techniques; Cell Line; Cell Shape; Cell Survival; Collagen; Coloring Agents; Cytoprotection; Diphosphonates; Drug Carriers; Durapatite; Female; Fibroblasts; Fluoresceins; Fluorescent Dyes; Gingiva; Humans; Imidazoles; Models, Animal; Osteoblasts; Osteogenesis; Protective Agents; Rabbits; Razoxane; Tetrazolium Salts; Thiazoles; Tibia; Zoledronic Acid | 2012 |
Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
Topics: Analysis of Variance; Antigens, CD; Bone Density Conservation Agents; Cell Line, Tumor; Diphosphonates; Flow Cytometry; Fluoresceins; Glioblastoma; Humans; Imidazoles; Leukocytes, Mononuclear; Lymphocyte Activation; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Time Factors; Zoledronic Acid | 2014 |